Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease

The human intestinal tract harbors large bacterial community consisting of commensal, symbiotic, and pathogenic strains, which are constantly interacting with the intestinal immune system. This interaction elicits a non-pathological basal level of immune responses and contributes to shaping both the...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 7; p. 367
Main Authors Sidiq, Tabasum, Yoshihama, Sayuri, Downs, Isaac, Kobayashi, Koichi S
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 20.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The human intestinal tract harbors large bacterial community consisting of commensal, symbiotic, and pathogenic strains, which are constantly interacting with the intestinal immune system. This interaction elicits a non-pathological basal level of immune responses and contributes to shaping both the intestinal immune system and bacterial community. Recent studies on human microbiota are revealing the critical role of intestinal bacterial community in the pathogenesis of both systemic and intestinal diseases, including Crohn's disease (CD). NOD2 plays a key role in the regulation of microbiota in the small intestine. is highly expressed in ileal Paneth cells that provide critical mechanism for the regulation of ileal microbiota through the secretion of anti-bacterial compounds. Genome mapping of CD patients revealed that loss of function mutations in are associated with ileal CD. Genome-wide association studies further demonstrated that is one of the most critical genetic factor linked to ileal CD. The bacterial community in the ileum is indeed dysregulated in -deficient mice. -deficient ileal epithelia exhibit impaired ability of killing bacteria. Thus, altered interactions between ileal microbiota and mucosal immunity through mutations play significant roles in the disease susceptibility and pathogenesis in CD patients, thereby depicting NOD2 as a critical regulator of ileal microbiota and CD.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Amélia M. Sarmento, Fernando Pessoa University, Portugal
Specialty section: This article was submitted to Mucosal Immunity, a section of the journal Frontiers in Immunology
Reviewed by: Dario S. Zamboni, University of São Paulo, Brazil; Geanncarlo Lugo-Villarino, Institute of Pharmacology and Structural Biology (CNRS), France; Lynnette Robin Ferguson, University of Auckland, New Zealand
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2016.00367